Evidence map›Paper›PMID 30638300›Full record

ArticleJournal of thrombosis and haemostasis : JTH2019

Human low-affinity IgG receptor FcγRIIA polymorphism H131R associates with subclinical atherosclerosis and increased platelet activity in systemic lupus erythematosus.

Robert Clancy, Hanane El Bannoudi, Sara E Rasmussen, Nicole Bornkamp, Nicole Allen, Rebecca Dann, Harmony Reynolds, Jill P Buyon, Jeffrey S Berger

Open access · bronzeAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Association ofFrontiers in immunology · 2025
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Biomedicines · 2022
    Article
  12. Article
  13. Cardiovascular disease in systemic lupus erythematosus.Rheumatology and immunology research · 2021
    Review
  14. Review
  15. Review
  16. Article
  17. Common innate pathways to autoimmune disease.Clinical immunology (Orlando, Fla.) · 2020
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Robert ClancyDepartment of Medicine, Division of Rheumatology, NYU Langone Medical Center, New York, NY, , USA.
Hanane El BannoudiDepartment of Medicine, Division of Cardiology, NYU Langone Medical Center, New York, NY, USA.
Sara E RasmussenDepartment of Medicine, Division of Rheumatology, NYU Langone Medical Center, New York, NY, , USA.
Nicole BornkampDepartment of Medicine, Division of Rheumatology, NYU Langone Medical Center, New York, NY, , USA.
Nicole AllenDepartment of Medicine, Division of Cardiology, NYU Langone Medical Center, New York, NY, USA.
Rebecca DannDepartment of Medicine, Division of Cardiology, NYU Langone Medical Center, New York, NY, USA.
Harmony ReynoldsDepartment of Medicine, Division of Cardiology, NYU Langone Medical Center, New York, NY, USA.
Jill P BuyonDepartment of Medicine, Division of Rheumatology, NYU Langone Medical Center, New York, NY, , USA.
Jeffrey S BergerDepartment of Medicine, Division of Cardiology, NYU Langone Medical Center, New York, NY, USA.
NYU Langone Health · US

Funding

Platelet Activity and Vascular Health in Systemic Lupus ErythematosusR01HL139909 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BERGER, JEFFREY S, BUYON, JILL P · 2018 to 2022
$4.3M
FcRIIA, Platelet Activity, and Vasculopathy in Systemic Lupus ErythematosusR21AR071103 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BERGER, JEFFREY S, BUYON, JILL P · 2017 to 2018
$410k
NHLBI NIH HHS R01 HL139909NIAMS NIH HHS R21 AR071103
6 · The paper itself

Abstract

Essentials Systemic lupus erythematosus (SLE) patients are at increased risk for premature CVD. Platelet activity, vascular dysfunction and carotid artery plaque are associated with FcγRIIA genotype in SLE. FcγRIIA genotype was not associated with platelet activity or carotid plaque in healthy controls. FcγRIIA represents a link that connects platelet activity, vascular health and CVD in SLE. SUMMARY: Background Systemic lupus erythematosus (SLE) is a complex autoimmune disease associated with an elevated risk of premature cardiovascular disease. Platelets express receptors contributing to inflammation and immunity, including FcγRIIA, the low affinity receptor of the Fc portion of IgG antibodies. The variation at a single amino acid substitution, H131R, in the extracellular binding domain alters the affinity for IgG, which may account for individual variation in platelet activity and platelet-mediated disease. Objectives This study was performed to investigate the association between FcγRIIA genotype, preclinical atherosclerosis, platelet reactivity and vascular health. Methods FcγRIIA was genotyped in 80 SLE patients and 30 healthy controls. Carotid ultrasound plaque, soluble E-selectin and platelet aggregability were evaluated in SLE and matched controls. Results Carotid plaque was significantly more prevalent in SLE patients carrying a variant allele compared to those with a homozygous ancestral allele (58% vs. 25%, P = 0.04). In contrast, prevalent carotid plaque was not associated with genotype in controls. Consistently, SLE variant FcγRIIA carriers vs. ancestral allele carriers had a significant increase in the levels of soluble E-selectin, which was not observed in controls. Monocyte and leukocyte-platelet aggregation and platelet aggregation in response to submaximal agonist stimulation were significantly elevated in SLE patients with the variant vs. ancestral genotype. Conclusions Carotid ultrasound plaque, soluble E-selectin levels and platelet activity were more frequently prevalent in SLE patients carrying variant FcγRIIA. The interplay between FcγRIIA-mediated platelet activation and endothelial cells might represent a mechanism underlying the pathogenesis of cardiovascular disease in SLE patients.

Indexed as

Polymorphism, GeneticAdultAsymptomatic DiseasesBiomarkersCarotid Artery DiseasesCase-Control StudiesE-SelectinFemaleGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseHeterozygoteHomozygoteHumansLupus Erythematosus, SystemicMaleBiomarkersE-SelectinFCGR2A protein, humanReceptors, IgGSELE protein, humanatherosclerosiscardiovascular diseaseFcγRIIAplateletssystemic lupus erythematosus (SLE)

Identifiers

PMID30638300
PMCPMC6440197
OpenAlexW2909223654

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.